| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TXN | Common Stock | Options Exercise | $5.13M | +97K | +23.71% | $52.93 | 506K | Feb 27, 2025 | Direct | |
| transaction | TXN | Common Stock | Sale | -$958K | -5K | -0.99% | $191.61 | 501K | Feb 27, 2025 | Direct | F1 |
| transaction | TXN | Common Stock | Sale | -$453K | -2.35K | -0.47% | $192.55 | 499K | Feb 27, 2025 | Direct | F2 |
| transaction | TXN | Common Stock | Sale | -$1.28M | -6.6K | -1.32% | $194.12 | 492K | Feb 27, 2025 | Direct | F3 |
| transaction | TXN | Common Stock | Sale | -$6.12M | -31.4K | -6.38% | $194.85 | 461K | Feb 27, 2025 | Direct | F4 |
| transaction | TXN | Common Stock | Sale | -$4.07M | -20.8K | -4.51% | $195.94 | 440K | Feb 27, 2025 | Direct | F5 |
| transaction | TXN | Common Stock | Sale | -$4.87M | -24.8K | -5.63% | $196.74 | 415K | Feb 27, 2025 | Direct | F6 |
| transaction | TXN | Common Stock | Sale | -$1.21M | -6.12K | -1.47% | $197.62 | 409K | Feb 27, 2025 | Direct | F7 |
| transaction | TXN | Common Stock | Options Exercise | $241K | +4.56K | +1.11% | $52.93 | 414K | Feb 28, 2025 | Direct | |
| transaction | TXN | Common Stock | Sale | -$121K | -629 | -0.15% | $192.15 | 413K | Feb 28, 2025 | Direct | F8 |
| transaction | TXN | Common Stock | Sale | -$233K | -1.21K | -0.29% | $193.35 | 412K | Feb 28, 2025 | Direct | F9 |
| transaction | TXN | Common Stock | Sale | -$343K | -1.76K | -0.43% | $194.66 | 410K | Feb 28, 2025 | Direct | F10 |
| transaction | TXN | Common Stock | Sale | -$188K | -959 | -0.23% | $195.82 | 409K | Feb 28, 2025 | Direct | F11 |
| holding | TXN | Common Stock | 308 | Feb 27, 2025 | By Trust 401(k) | F12 | |||||
| holding | TXN | Common Stock | 12.7K | Feb 27, 2025 | By Trust PS | F13 | |||||
| holding | TXN | Common Stock | 48.8K | Feb 27, 2025 | By Children | F14 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TXN | NQ Stock Option (Right to Buy) | Options Exercise | $0 | -97K | -95.51% | $0.00 | 4.56K | Feb 27, 2025 | Common Stock | 97K | $52.93 | Direct | F15 |
| transaction | TXN | NQ Stock Option (Right to Buy) | Options Exercise | $0 | -4.56K | -100% | $0.00 | 0 | Feb 28, 2025 | Common Stock | 4.56K | $52.93 | Direct | F15 |
| Id | Content |
|---|---|
| F1 | The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $191.25 to $192.24. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. |
| F2 | The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $192.25 to $192.975. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. |
| F3 | The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $193.405 to $194.39. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. |
| F4 | The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $194.41 to $195.4. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. |
| F5 | The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $195.415 to $196.41. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. |
| F6 | The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $196.42 to $197.38. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. |
| F7 | The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $197.42 to $197.945. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. |
| F8 | The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $191.62 to $192.595. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. |
| F9 | The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $192.805 to $193.62. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. |
| F10 | The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $194.215 to $195.105. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. |
| F11 | The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $195.275 to $196.04. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. |
| F12 | Estimated shares attributable to TI 401(k) Account as of 12/31/2024. (Interests in this account are denominated in units. Consequently, share amount shown is an estimate.) This statement does not include changes in beneficial ownership of shares held in this account occurring after 12/31/2024 that are eligible for deferred reporting on Form 5. |
| F13 | Estimated shares attributable to TI Universal Profit Sharing Account as of 12/31/2024. (Interests in this account are denominated in units. Consequently, share amount shown is an estimate.) This statement does not include changes in beneficial ownership of shares held in such account occurring after 12/31/2024 that are eligible for deferred reporting on Form 5. |
| F14 | Shares held in trusts for benefit of children; beneficial ownership by reporting person disclaimed. |
| F15 | The option became exercisable in four equal annual installments beginning on January 29, 2017. |